Candidaemia in the immunocompromised; a case for early diagnosis/detection and treatment

Abstract

Invasive fungal infections especially in the immunocompromised patient have become a target for empiric and prompt preemptive therapy due to the associated high mortality and hospital costs. It is for these reasons that newer laboratory tests are being formulated to drive early therapeutic interventions so that mortality associated with invasive fungal infections can be minimized.

Jos Journal of Medicine, Volume 7 No. 2